Tafamidis decreased cardiac amyloidosis deposition in patients with Ala97Ser hereditary transthyretin cardiomyopathy: a 12-month follow-up cohort study

BACKGROUND: Transthyretin cardiac cardiomyopathy (ATTR-CM) is a rare but life-threatening disease. Tafamidis is an effective treatment for patients with ATTR-CM, however its long-term effects on cardiac remodeling and cardiac amyloid deposition are unknown. This study aimed to used cardiac magnetic...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Cheng-Hsuan, Chao, Chi-Chao, Hsieh, Sung-Tsang, Yu, An-Li, Wu, Yuan-Kun (Aden), Cheng, Mei-Fang, Lee, Ming-Jen, Chou, Chia-Hung, Shun, Chia-Tung, Hsueh, Hsueh-Wen, Jyh-Ming Juang, Jimmy, Tseng, Ping-Huei, Su, Mao-Yuan, Lin, Yen-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498629/
https://www.ncbi.nlm.nih.gov/pubmed/37705003
http://dx.doi.org/10.1186/s13023-023-02824-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498629/
https://www.ncbi.nlm.nih.gov/pubmed/37705003
http://dx.doi.org/10.1186/s13023-023-02824-0

Ejemplares similares